On May 27, 2012, Cipher Pharmaceuticals (T.DND) announced it had received U.S. FDA approval of Absorica, the company's novel, patented brand formulation of the acne medication isotretinoin, for the ...

Isotretinoin 8mg, 16mg, 20mg, 24mg, 28mg, 32mg; hard gelatin caps; contains soy. Isotretinoin is a retinoid, which when administered at the recommended dosage, inhibits sebaceous gland function and ...

Patients with severe acne have a lower dose isotretinoin option available, now that Sun Pharma is introducing Absorica LD (isotretinoin) capsules. The product is indicated for the management of severe ...

Agreement expanded to include a portfolio of novel isotretinoin products New portfolio royalty extends through December 2024 MISSISSAUGA, ON, July 30, 2018 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH ...

Total net Absorica revenues in the third quarter 2013 were $4.5 million, comprised of $0.5 million in amortization of upfront licensing fee and $4.0 million in royalties on U.S. sales at Ranbaxy. We ...

Ranbaxy announced the launch of Absorica (isotretinoin) 25mg and 35mg capsules for the treatment of severe recalcitrant nodular acne in patients ≥12 years old. Absorica is a retinoid that inhibits ...

"This micronized formulation provides many Canadians with a novel solution to deal with severe nodular acne," said Abhay Gandhi, North America CEO of Sun Pharma. "As demonstrated by this new treatment ...

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced its launch of the first ...

What is isotretinoin used for? Isotretinoin is used to treat a certain type of severe acne vulgaris (nodular acne) that has not responded to other treatments. Isotretinoin may also be used for other ...

Ranbaxy Laboratories, on Monday, announced that it had received approval from the U.S. Food and Drug Administration to launch Absorica, a patented acne treatment drug developed by Canadian firm Cipher ...

Ranbaxy Laboratories is going to launch Cipher Pharma's Absorica in US in October-December. The company will make USD 9 million milestone payment to Cipher for Absorica, reports CNBC-TV18. It touched ...

We remind investors that in August 2008, the company entered into a distribution and supply agreement with Ranbaxy Pharmaceuticals Inc., under which Cipher granted Ranbaxy the exclusive right to ...